Objective: The aim of this study was to investigate the effect of obesity on dispersion of P-wave duration and QTc interval in obese women. Methods: Forty-two obese women (Body mass index (BMI) ¼ 4073 kg/m 2 , mean age 4579 years) and compared agematched (BMI ¼ 2271 kg/m 2 , mean age 4176 years) twenty-five non-obese women were included in our study. Maximum and minimum P-wave duration, P-wave dispersion (difference between the maximum and the minimum P-wave duration), maximum and minimum QTc interval, and QTc dispersion (the difference between the maximum and the minimum QTc interval) were measured from 12-lead ECG. ECG's were transferred to a personal computer via a scanner and then used for magnification of 400 times by Adobe Photoshop software. Results: There was significant difference in BMI (4073 vs 2271 kg/m 2 , Po0.001, respectively) between obese and non-obese women. Obese women had higher Max. P-wave duration (116711 vs 94714 ms, Po0.001), P-wave dispersion (51715 vs 26711 ms, Po0.001), Max. QTc interval (449738 vs 419730 ms, Po0.001) and QTc dispersion (57723 vs 38715 ms, Po0.001) compared to non-obese women. A significant correlation was found between BMI and Max. P-wave duration (r ¼ 0.584, Po0.001), P-wave dispersion (r ¼ 0.621, Po0.001), Max. QTc interval (r ¼ 0.410, Po0.001), and QTc dispersion (r ¼ 0.429, Po0.001). In the linear regression analysis, compared to co-morbidity factors such as age, hypertension, diabetes mellitus and smoking, there was significant association between only BMI and electrocardiographic values (P-wave and QTc dispersion). Conclusion: We concluded that obesity caused significant increase in P-wave and QTc dispersion. Therefore, obese women may not only be under the risk of ventricular arrhythmias, but also they may under the risk of atrial arrhythmias.
Introduction
We know that morbid obesity may cause changes in cardiac morphology such as left atrial and ventricular enlargement, with eccentric LV hypertrophy and right ventricular hypertrophy. [1] [2] [3] In addition to the changes in cardiac anatomy, morbid obesity may also alter the electrocardiogram (ECG). P-wave dispersion, which is the difference between maximum and minimum P-wave duration, has been recently defined as a new electrographic marker for the prediction of atrial fibrillation (AF) 4 and it is found to be associated with inhomogeneous and discontinuous propagation of sinus impulses. 4, 5 Although, in the Framingham Heart Study 6 body mass index (BMI) was not defined as an independent risk factor for AF, according to a recent study by Wang et al. 7 obesity has proved as an important, potential risk factor for AF. The association of obesity with subsequent development of AF persists even after accounting for the influence of concominant conditions such as hypertension (HT), diabetes mellitus (DM) and myocardial infarction. Dispersion of the QTc interval is a measure of interleads QT variability, and it reflects regional variation in ventricular repolarization. An increased QTc dispersion is a possible substrate for ventricular arrhythmias and sudden death. 8 Increase in the QT interval has been reported in obese subjects in various studies. [9] [10] [11] [12] However, the results of these studies are controversial. We hypothesized that obesity is associated with the increase in the duration and dispersion of P-wave and QTc interval. As far as we know, there is no previous study exactly defining the duration and dipersion of P-wave in obese subjects. The aim of this study was to investigate the dispersion of P-wave and QTc in obese women.
Methods
Forty-nine obese women and 25 non-obese women were admitted to cardiology and internal medicine outpatient clinics of our hospital and were included in the study consecutively. Medical history, physical examination, laboratory tests (complete blood count, electrolytes, thyroid hormones) and ECG recordings were performed on the subjects in the study population. Subjects with thyroid dysfunction, anemia, electrolyte imbalance, known valvular heart disease, heart failure, and coronary artery disease and ECG abnormalities such as left bundle branch block, atrioventricular conduction defect in background were excluded. Seven of 49 obese women (four subjects with coronary artery disease, two subjects with hypothyroidy and one subject using antiarrhythmic drug (amiodarone)) were excluded from the study. Thus, only the remaining 42 obese women were included in this study. All of the obese and nonobese women included in the study were in sinus rhythm and none of them were taking medications like antiarrhythmic agents, trisyclic antidepressants, antihistaminics and antipsychotics. Height and weight were directly measured by using a standardized protocol. BMI was calculated by dividing weight in kilograms by the square of the height in meters. Obesity was defined as X30 kg/m 2 of BMI. Normal weight was defined as p25 kg/m 2 of BMI.
To avoid from diurnal variations, we generally took the ECG recordings of all the obese and non-obese subjects at the same time interval (1000-1200 hrs). All subjects underwent a routine standart 12-lead surface ECG recorded at a paper speed of 25 mm/s and gain of 10 mm/mV (Cardiofax V, Nihon Kohden Corp., Tokyo, Japan) in the supine position and were breathing freely but not allowed to speak during the ECG recording. ECG's were transferred to a personal computer (PC) via a scanner and then magnified 400 times by Adobe Photoshop software. The starting point of P-wave was referred as the positive deflection crossing the isoelectric line and the end point was referred as the end of the deflection crossing the isoelectric line. P-wave duration was measured from the onset to the offset of the P-wave. We accepted maximum (Max.) P-wave duration as longest P-wave duration and minimum (Min.) P-wave duration as the shortest P-wave duration. P-wave dispersion that is defined as the difference between the Max. P-wave duration and the Min. P-wave duration was also calculated. The subjects were excluded if these points were not clear. QT interval which is the duration between the beginning of QRS complex to the end of T-wave was measured in all derivations in which T-wave was clearly seen and not mixed with a U-wave. The longest QT interval (Max. QT) and the shortest QT interval (Min. QT) were measured. The average of QT intervals measured in all of derivations was accepted as mean QT interval. Measured QT intervals were corrected by Bazett's formula 13 (QTc ¼ QT/RR) and defined as corrected QT interval (QTc). The difference between the longest QTc interval (Max. QTc) and the shortest QTc interval (Min. QTc) was also defined as QTc dispersion. In all subjects, derivations in which the beginning and end point of QT could not be distinguished were excluded. All the measurements were repeated three times and average values were accepted for each of ECG values. All the measurements were performed by two experienced investigators unaware of the subject's clinical status. The study protocol was approved by the local Ethics Committee, and informed written consents were obtained from each patient at the start of the study. 
Results
Baseline clinical characteristics and the medications used by obese subjects who had DM and HT are shown in Table 1 . Age was similar between obese and non-obese women.
Compared to non-obese women, obese women had higher ratio of HT and DM. Heart rate and PR duration were not different between obese and non-obese women ( Table 2) .
P-wave duration and dispersion
Obese women had higher Max. P-wave duration (Po0.001) and P-wave dispersion (Po0.001) compared to non-obese. Although, Min. P-wave duration (P40.05) was found higher in obese compared to non-obese women, no statistical significance was found (Table 2) . A significant correlation was found between BMI and Max. P-wave duration (r ¼ 0.584, Po0.001), and P-wave dispersion (r ¼ 0.621, Po0.001). However, in the linear regression analyses, compared to cardiovascular risk factors such as age, HT, DM, smoking, there was significant association between only BMI and Max. P-wave duration, and dispersion ( Table 3 ). The distribution of P-wave dispersion is shown in Figure 1 .
QT interval and dispersion
Maximum QTc interval (Po0.001) and QTc dispersion (Po0.001) were found to be higher in obese than in nonobese women. Min. QTc interval (P40.05) and QTc interval (P40.05) were not found to be statistically higher in obese compared to non-obese women ( Table 3 ). The distribution of QTc dispersion is shown in Figure 2 . 
P-wave and QT dispersion in obese women
E Seyfeli et al
Discussion
In this study, we noted several findings: (1) P-wave dispersion and QTc dispersion were significantly longer in obese compared with non-obese women. In the statistical correlation analyses, a significant correlation was found to present between BMI and electrocardiographic values (P-wave dispersion and QTc dispersion). (2) In the linear regression analyses, there was significant association between only BMI and electrocardiographic values (P-wave dispersion and QTc dispersion). There was no statistically significant association between cardiovascular risk factors such as age, smoking, HT, and DM, with P-wave dispersion and QTc dispersion.
P-wave duration and dispersion
It is well known that obese patients are under the risk of ventricular arrhythmias and sudden death. 14, 15 However, association between obesity and AF was not exactly clarified until recently. Wang et al. 7 previously have shown that obesity is a risk factor for AF, and they observed that obesity was associated with a 50% increase in the risk of AF. Furthermore, Frost et al. 16 have suggested that AF and flutter should be added to the list of diseases caused by overweight and obesity. To our knowledge, there is no previous information about the association of obesity with increased P-wave duration and P-wave dispersion. In our study, obese women had higher Max. P-wave duration, and P-wave dispersion compared with non-obese women. Left atrial enlargement, which is an important precursor of AF, 17 may contribute to the increase in P-wave duration and P-wave dispersion associated with obesity. Some studies have shown that BMI is one of the most powerful determinants of left atrial size. 18, 19 In obese patients, left atrial enlargement and electrical instability may be caused by elevated plasma volume, ventricular diastolic dysfunction and enhanced neurohormonal activity. It has been previously reported that changes in left atrial dimension and pressure may influence P-wave duration. 20 We feel that further studies are required to figure out the relation between the decrease of P-wave dispersion and regression of left atrial diameter after weight loss in obese subjects.
QTc interval and dispersion
In previous studies, the abnormalities of ventricular repolarization has been widely recognized with different results in obese subjects. Girola et al. 12 shown that there was no correlation between BMI and QTc interval in uncomplicated obese women and reported that QT dispersion did not correlate with age, BMI, waist circumference, or abdominal sagittal diameter in the regression analyses. In another study, Nomura et al. 21 evaluated the effect of obesity on ECG values in coronary patients and observed that the ECG values (except QT dispersion) are not different in normal, overweight, and obese coronary patients. Furthermore, they found lower QT dispersion in overweight compared to normal-weight patients. In contrast, some studies have shown increase in QTc interval in obese subjects. [7] [8] [9] Our findings support the association between delayed ventricular repolarization and obesity. In the current study, we found a significant increase in QTc dispersion and Max. QTc interval in obese compared with non-obese women. We feel that this difference between studies may be due to the heterogenicity of study populations and different techniques used to measure QT intervals or it may be due to possible measurement errors. The manual measurement of QT interval may limit its accuracy. It has been reported that scanning and digitizing ECG signals from paper records using an optical scanner is a feasible and accurate alternative method. 22 The functional and structural changes in heart, 1,23 hyperinsulinemia, glucose intolerance, 24 and autonomic dysfunction 25 may also effect the QTc interval in obese subjects.
Even in the absence of any apparent complications, obesity may be accompanied by minimal asymptomatic myocardial dysfunction. 26, 27 However, co-morbidity factors such as HT and DM may effect ECG values. 28, 29 According to the results of the linear regression analyses carried out in the current study, we did not find any association between co-morbidity factors with P-wave and QTc dispersion, which may indicate that these comorbity factors do not have a considerable effect on ECG. This study have several limitations.
(1) The present study was done in a relatively small population such that women with BMI between 25 and 30 kg/m 2 were not included. (2) Echocardiography and 24 h ECG monitoring were not performed. In addition, we did not evaluate the ECG findings of atrial dilatation and ventricular hypertrophy because of lower sensitivity of ECG in obese subjects. (3) We did not measure waist-to-hip ratio and waist circumference. We concluded that P-wave duration and dispersion as well as QTc dispersion are significantly longer in obese than in non-obese women. The results of the present study suggest that obese subjects may not only be under the risk of ventricular arrhythmias, but also they may be under the risk of atrial arrhythmias such as AF. Consequently, the current study shows that obesity may have implications both for Pwave dispersion and for QTc dispersion.
